Acumen Pharmaceuticals, Inc. (ABOS) income statement
ABOSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.19−0.01 (-3.52%)
Close on Nov 20, 2026Market cap $13.49MP/E –Yield –
Acumen Pharmaceuticals, Inc. financial ratios
See a number that looks wrong?